Northrop Grumman Corporation

ticker: NOC step: 01 generated: 2026-05-12 source: quick-research

Northrop Grumman Corporation (NOC) — Business Overview

Business Description

Northrop Grumman is one of the top-5 US defense primes (alongside Lockheed Martin, RTX, General Dynamics, Boeing), uniquely positioned at the intersection of strategic deterrence (B-21 Raider next-gen stealth bomber + LGM-35A Sentinel ICBM), space systems (national security space, missile defense), mission systems (radar, sensors, cyber, electronic warfare), and defense systems (munitions, weapons). The company is led by CEO Kathy Warden. FY25 revenue ~$44B; record $95.7B backlog. The B-21 Raider production ramp (25% acceleration agreement) + Sentinel ICBM restructuring + CCA / autonomous systems + munitions expansion create a multi-year "Deterrence Super-Cycle" thesis with material upside in 2027-28.

Revenue Model

Four reportable segments (FY2025 revenue):

• Aeronautics Systems ($12.99B, ~29%, +8%) — B-21 Raider, B-2 Spirit, F-35 (sub-contract), Triton/Global Hawk surveillance UAS, X-47 autonomy, E-2D Hawkeye.
• Mission Systems ($12.51B, ~29%, +9.7%) — Radar (APG-83, APG-81 for F-35), electronic warfare (SEWIP), C4I, advanced computing, cyber, naval weapons.
• Space Systems ($10.77B, ~25%, -8.2%) — Sentinel ICBM (LGM-35A), national security space, NGAD space components, Cygnus cargo (ISS), missile defense (NGI Next Generation Interceptor).
• Defense Systems ($8.00B, ~18%) — Munitions, weapons, ground combat, propellants, fire-control.

Revenue is overwhelmingly long-cycle (multi-year cost-plus + fixed-price contracts) with US Government as ~80%+ customer.

Products & Services

• B-21 Raider Stealth Bomber: Successor to B-2; 25% production acceleration agreement; multi-decade program. Combat-ready 2029.
• Sentinel ICBM (LGM-35A): Replaces Minuteman III; under restructuring through late 2026; test launch 2027; operational early 2030s. $200M near-term + $2.5B multi-year capex commitment.
• Triton + Global Hawk UAS: Maritime + high-altitude surveillance.
• Cygnus: ISS cargo resupply (NASA).
• NGI (Next Generation Interceptor): Missile defense; competing with Lockheed.
• Collaborative Combat Aircraft (CCA): Autonomous wingmen for F-35/NGAD; emerging program with material 2027-28 upside.
• APG-83 + APG-81 AESA radars: F-16 + F-35 fighter radars.
• SEWIP: Surface Electronic Warfare Improvement Program (Navy).
• Munitions / Weapons: AARGM-ER, AGM-88E, Stand-In Attack Weapon (SiAW); munitions expansion driven by Ukraine + Israel + Pacific demand.

Customer Base & Go-to-Market

• US Department of Defense (~80% of revenue): All military services + DARPA + Missile Defense Agency.
• NASA (~5%): Cygnus + space science programs.
• Foreign Military Sales (~15%): Various NATO + Pacific allies (Australia, Japan, Korea).
• Commercial: Smaller; mostly Cygnus + small business spinoffs.

Distribution: Direct US government contracts; foreign military sales via Government channels; multi-year cost-plus + fixed-price agreements.

Competitive Position

Northrop occupies a unique niche in US defense — the dominant stealth bomber + ICBM + national security space prime:

1. B-21 Raider sole-source — Only fifth-generation stealth bomber in development; multi-decade $200B+ lifetime program value.
2. Sentinel ICBM sole-source — Replaces Minuteman III; multi-decade $140B+ program.
3. National security space leadership — Cygnus + classified space programs.
4. Mission Systems radar/EW depth — Sensors + electronic warfare leadership.

Competitive positioning vs. peers:

• Lockheed Martin — Larger; F-35 dominant; NGI competitor; Aegis.
• RTX (Raytheon Technologies) — Munitions + space + Pratt & Whitney engines.
• General Dynamics — IT services + munitions + naval.
• Boeing Defense — F-15EX + KC-46 + apache; recovering from execution issues.

Structural advantages:

1. Backlog at record $95.7B — Multi-year revenue visibility.
2. Defense budget tailwind — US FY2027 budget request proposes +44% increase; NATO 2% commitments + Pacific deterrence buildup.
3. B-21 + Sentinel multi-decade programs — Long-lifecycle revenue streams; high switching costs.
4. Mission Systems mix — Higher-margin technology content vs. heavy industrial.

Challenges:

• Sentinel restructuring overhang — Multi-billion overruns, Department of Defense oversight; could continue compressing margins.
• Space Systems -8.2% in FY25 — Off legacy program rolls + Sentinel restructuring.
• B-21 cost overruns — Fixed-price LRIP contract creates margin risk.
• Supply chain + workforce constraints — Critical components, skilled labor shortages.

Key Facts

• Founded: 1939 (Northrop Aircraft); 1994 merger with Grumman
• Headquarters: Falls Church, Virginia
• Employees: ~100,000+
• Exchange: NYSE
• Sector / Industry: Industrials / Aerospace & Defense
• Market Cap: ~$80B
• FY2024 Revenue: $41.0B (+4%)
• FY2025 Revenue: ~$44B
• Backlog: $95.7B record
• B-21 Production Acceleration: 25% capacity increase agreement
• Q1 2026 Revenue: $9.9B; EPS $6.14
• 2026 Revenue Guide: $43.5–44.0B
• 2026 Segment Operating Margin Guide: Low-to-mid 11% range
• FY2025 Free Cash Flow: $3.3B (+26% YoY)
• Dividend Yield: ~1.5%
• CEO: Kathy Warden (since 2019)

ticker: NOC step: 04 generated: 2026-05-12 source: quick-research

Northrop Grumman Corporation (NOC) — Financial Snapshot

Income Statement Summary

Segment Detail (FY2025 — Revenue)

Q1 2026 Results

FY2026 Guidance

Cash Flow & Capital Allocation (FY2025)

Key Ratios (approximate)

• P/E: ~21x (FY26E EPS ~$28) | EV/EBITDA: ~14x | FCF Yield: ~4%
• Revenue Growth (FY25): +7% (Backlog +6%)
• Segment Operating Margin: ~11.2%
• Dividend Yield: ~1.5%
• Book/Bill Ratio: >1.1x (multi-year revenue visibility)

Growth Profile

FY25 was a strong year operationally:

• Revenue +7% to $44B
• FCF +26% to $3.3B
• Backlog at record $95.7B
• B-21 25% production acceleration agreement signed
• Sentinel restructuring progressing toward late-2026 conclusion

Q1 2026 setup ($9.9B revenue + $6.14 EPS) confirms operational momentum continuing.

The 2026-2028 narrative:

• 2026: Production ramps + Sentinel restructuring conclusion (margin pressure subsides)
• 2027: B-21 acceleration material; CCA program ramps; Sentinel test launch
• 2028: B-21 + CCA + munitions all at higher production cadence; margins expand

CEO Warden has framed 2026 as a "balanced" year with major revenue impacts pushed to 2027–28. The 2027-28 setup includes "unpriced upside" not in current guidance from B-21 acceleration + CCA + munitions expansion.

Forward Estimates

FY2026 Guide:

• Revenue: $43.5–44.0B (flat to slightly up)
• Segment Operating Margin: 11.2–11.6%
• Adjusted EPS: ~$27.50–29.00 consensus

Bull case: B-21 acceleration starts contributing in late 2026; Sentinel restructuring concludes cleanly; CCA program awards; munitions expansion drives 2027 revenue +12-15%; multiple expands to 24x P/E; stock could reach $700+ vs. $565 currently. Bear case: B-21 cost overruns; Sentinel margin pressure extends; defense budget delays; multiple compresses to 18x P/E. Consensus targets ~$650–720 vs. trading ~$555–585 (~12–25% implied upside).

ticker: NOC step: 12 generated: 2026-05-12 source: quick-research

Northrop Grumman Corporation (NOC) — Investment Catalysts & Risks

Bull Case Drivers

1. B-21 Raider 25% production acceleration agreement — Multi-billion-dollar incremental program value over the next decade. $200M near-term + $2.5B multi-year capex commitment. Material revenue impact in 2027-28 not in current guidance — pure upside.
2. Record $95.7B backlog — Multi-year revenue visibility unmatched in defense. Book-to-bill >1.1x sustainable.
3. US defense budget tailwind — FY2027 request proposes 44% increase; sustained Pacific + Ukraine + Israel demand; NATO 2% commitments; Middle East deterrence buildup.
4. Sole-source on multiple strategic programs — B-21, Sentinel ICBM, NGI, classified space, Triton — these are not contestable; multi-decade revenue streams.
5. Mission Systems +9.7% growth — Higher-margin radar + EW + sensors growing fastest; tech-content mix improving.
6. Munitions expansion — Ukraine + Israel + Pacific demand driving multi-year munitions capacity expansion (AARGM-ER, Hellfire, Stand-In Attack Weapon, etc.).
7. Sentinel restructuring concludes late 2026 — Removes a multi-quarter overhang; margins should expand as restructuring costs roll off.
8. CCA (Collaborative Combat Aircraft) emerging program — Autonomous wingmen for F-35/NGAD; potential multi-billion program win in 2027.
9. Free Cash Flow +26% in FY25 to $3.3B — Cash generation accelerating despite Sentinel restructuring drag.
10. Capital return $3B+ annually — ~$1.6B buybacks + ~$1.4B dividends; sustainable through cycle.

Bear Case Risks

1. B-21 cost overruns under fixed-price LRIP contracts — Low-Rate Initial Production contracts are fixed-price; further cost overruns directly hit Aeronautics margins. B-21 has already taken meaningful charges.
2. Sentinel ICBM continued overruns — Multi-billion overruns through 2024-25; Department of Defense oversight intensifying; restructuring could miss late-2026 conclusion timeline.
3. Space Systems -8.2% in FY25 — Off legacy program rolls + Sentinel restructuring; Space could continue underperforming through 2026.
4. Defense budget political uncertainty — Continuing resolutions + debt ceiling fights + administration changes create budget execution risk despite proposed budget growth.
5. Workforce / supply chain constraints — Critical components, skilled labor shortages for B-21, Sentinel, and munitions production ramp.
6. Cyclical commercial space exposure — Cygnus ISS resupply dependent on NASA budget + space launch cadence.
7. Foreign Military Sales execution — Multi-year sales cycles with allied governments; geopolitical timing risk.
8. Premium valuation (~21x FY26 P/E) — Defense sector premium; multiple compression if growth disappoints.

Upcoming Events

• Q2 2026 earnings (late July 2026): Mid-year guide check + Sentinel restructuring progress.
• Q3 2026 earnings (late October 2026): B-21 acceleration timing + CCA program updates.
• Sentinel restructuring conclusion (late 2026): Critical overhang removal.
• CCA program awards: Air Force decisions on Collaborative Combat Aircraft contracts.
• FY2027 Defense Budget appropriations: Multi-quarter visibility on production funding.
• Sentinel test launch (2027): Major program milestone.
• B-21 IOC (Initial Operational Capability): 2029 target.

Analyst Sentiment

Consensus rating is Buy / Overweight (~65% Buy, 32% Hold, 3% Sell). Price targets cluster $650–720 vs. trading ~$555–585 (~12–25% implied upside). Bull case targets ~$800 on B-21 acceleration + Sentinel resolution + CCA awards; bear case ~$480 on Sentinel overruns + B-21 cost issues. Wells Fargo, Bernstein, JPM, Morgan Stanley maintain Buy/Overweight; Truist at Buy; Goldman at Buy.

Research Date

Generated: 2026-05-12